An Umbrella Review of Effectiveness of Intravenous Ketamine in Treatment-Resistant Depression

被引：0
|
作者：
Klassen, A. M. [1 ]
Baten, C. [1 ]
Shepherd, J. H. [1 ]
Zamora, G. [1 ]
Johnson-Venegas, E. [1 ]
Madugula, S. S. [2 ]
Woo, E. [1 ]
Miller, J. A. [3 ]
Sacchet, M. D. [4 ]
Hedges, D. W. [5 ]
Miller, C. H. [1 ]
机构：
[1] Calif State Univ Fresno, Dept Psychol, Fresno, CA 93740 USA
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[3] Palo Alto Univ, Dept Psychol, Palo Alto, CA USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA
[5] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA
来源：
EUROPEAN PSYCHIATRY | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
O0099
引用
收藏
页码：S86 / S87
页数：2
相关论文
共 50 条
  • [31] Ketamine in Late Life Treatment-Resistant Depression
    Heard, Erika
    Sohail, Yousuf
    Nagar, Anusuiya
    Glass, Oliver M.
    Hermida, Adriana P.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 25 (03): : S66 - S66
  • [32] The role of intranasal ketamine in treatment-resistant depression
    Costa, M.
    Fraga, M.
    Moutinho, A.
    Cintra, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S492 - S492
  • [33] Maintenance Ketamine Therapy for Treatment-Resistant Depression
    Archer, Shaina
    Chrenek, Carson
    Swainson, Jennifer
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 380 - 384
  • [34] Magnesium in Ketamine Administration in Treatment-Resistant Depression
    Gorska, Natalia
    Cubala, Wieslaw Jerzy
    Slupski, Jakub
    Wiglusz, Mariusz Stanislaw
    Galuszko-Wegielnik, Maria
    Kawka, Mateusz
    Grzegorzewska, Agata
    PHARMACEUTICALS, 2021, 14 (05)
  • [35] KETAMINE FOR TREATMENT-RESISTANT DEPRESSION: A NEW ADVOCATE
    Perez-Esparza, Rodrigo
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (02): : 65 - 67
  • [36] Clinical Efficacy of Ketamine for Treatment-resistant Depression
    Bratsos, Sosipatros
    Saleh, Sohag N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
  • [37] Comparing the Effectiveness of IV Ketamine and Esketamine in a Group of Outpatients with Treatment-Resistant Depression
    Keshishyan, Anahit
    Silbersweig, Arielle
    Kim, Jonathan
    Coolidge, Sarah J.
    Tsygankova, Valeriya
    Celedon-Garcia, Rafael D.
    Richardon, Gabriel S.
    McDonald, William M.
    Kitay, Brandon M.
    Posse, Patricio Riva
    Hershenberg, Rachel
    Chatham, Anthony
    Hutchison, Charles
    Hermida, Adriana P.
    JOURNAL OF ECT, 2024, 40 (03) : E22 - E22
  • [38] Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
    Alnefeesi, Yazen
    Chen-Li, David
    Krane, Ella
    Jawad, Muhammad Youshay
    Rodrigues, Nelson B.
    Ceban, Felicia
    Di Vincenzo, Joshua D.
    Meshkat, Shakila
    Ho, Roger C. M.
    Gill, Hartej
    Teopiz, Kayla M.
    Cao, Bing
    Lee, Yena
    McIntyre, Roger S.
    Rosenblat, Joshua D.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2022, 151 : 693 - 709
  • [39] Oral ketamine for the treatment of pain and treatment-resistant depression
    Schoevers, Robert A.
    Chaves, Tharcila V.
    Balukova, Sonya M.
    aan het Rot, Marije
    Kortekaas, Rudie
    BRITISH JOURNAL OF PSYCHIATRY, 2016, 208 (02) : 108 - 113
  • [40] Intravenous Ketamine Treatment for Adolescents With Treatment-Resistant Depression: Clinical Effects and Impacts on Neural Structure
    Cullen, Kathryn
    Klimes-Dougan, Bonnie
    Lim, Kelvin
    Carstedt, Patricia
    Eberly, Lynn
    Roback, Mark
    Albott, Sophia
    Amatya, Palistha
    Mueller, Bryon
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S493 - S494
12345